New Prostate Cancer Test Ready for General Use

Health Discovery Corporation (HDC) announced Aug. 11 that its new gene-based molecular diagnostic test for prostate cancer has now successfully completed its phase III double-blind clinical trial. According to a Medical News Today report, the test is now ready for commercialization to be used by physicians on their patients at risk of having prostate cancer.

Latest posts by admin aapc (see all)

Comments are closed.